US$ 27.95
glp-1 ibd drugs calm inflammation beyond diabetes and weight loss Alimentary Pharmacology & Therapeutics |
Description
A new product claims to deliver Tirzepatide, the powerful injection used in FDA-approved drugs like Mounjaro and Zepbound, via a painless microneedle patch.

Constipation is a common but often overlooked side effect in people taking GLP-1 receptor agonists, a class of medications widely used to treat obesity and type 2 diabetes

Lowers the risk of kidney disease

start

In Study 2, the GLP-1 and diet/exercise targets were evaluated similarly, and both were rated more negatively than the target who maintained weight loss (ps0.001)